ACRX - AcelRx Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $52.51. This is a potential upside of $51.38 (4546.9%) from yesterday's end of day stock price of $1.13.

AcelRx Pharmaceuticals's activity chart (see below) currently has 20 price targets and 16 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 47.13 days.

Most recent stock forecast was given by ED ARCE from WESTPARK on 25-Sep-2023. First documented stock forecast 10-Mar-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Sep-2023

2 years 4 months 21 days ago
(25-Sep-2023)

0/3 (0%)

$95.4 (213.90%)

Buy

$160

4 years 2 months 13 days ago
(01-Dec-2021)

0/1 (0%)

$74.6 (87.35%)

Sell Since 20-Jul-2020

$16.6

$15.47 (1369.03%)

$16.8

5 years 3 months 9 days ago
(06-Nov-2020)

4/4 (100%)

$-12.4 (-42.76%)

335

Buy Since 09-May-2019

$120

$118.87 (10519.47%)

6 years 9 months 6 days ago
(09-May-2019)

0/1 (0%)

$56.4 (88.68%)

Buy Since 16-Aug-2018

$200

$198.87 (17599.12%)

$140

7 years 3 months 13 days ago
(02-Nov-2018)

0/2 (0%)

$104 (108.33%)

Show more analysts

Please expand the browser size to see the chart

What is ACRX (AcelRx Pharmaceuticals) average time for price targets to be met?

On average it took 47.13 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on ACRX (AcelRx Pharmaceuticals) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on ACRX (AcelRx Pharmaceuticals) with a proven track record?

MATTHEW ANDREWS

Which analyst has the most public recommendations on ACRX (AcelRx Pharmaceuticals)?

Evan Seigerman works at BMO and has 30 price targets and 16 ratings on ACRX

Which analyst is the currently most bullish on ACRX (AcelRx Pharmaceuticals)?

Michael Higgins with highest potential upside - $198.87

Which analyst is the currently most reserved on ACRX (AcelRx Pharmaceuticals)?

Brandon Folkes with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?